• Epalrestat Workflows for Neuroprotection Research

  2026-09-25

  Epalrestat offers researchers a way to connect polyol pathway inhibition with emerging KEAP1/Nrf2 neuroprotection studies. This workflow-focused guide translates Parkinson’s disease model findings into practical assay choices, controls, and troubleshooting steps—without treating preclinical evidence as clinical proof.

• GANT61 Disrupts the Hh–PIK3IP1–Akt Axis in ALK+ ALCL

  2026-09-25

  A 2026 study reports that the GLI inhibitor GANT61 suppresses proliferation, promotes cell-cycle arrest, and induces apoptosis in ALK-positive anaplastic large cell lymphoma cell lines. The findings connect GLI1 inhibition with increased PIK3IP1 expression and reduced Akt phosphorylation, suggesting a candidate signaling relationship that merits further causal testing.

• EPZ-6438 Workflow for EZH2-Driven Resistance

  2026-09-24

  Use EPZ-6438 to test how EZH2-dependent chromatin repression shapes cancer-cell responses, including resistance-related signaling in melanoma. This practical guide combines target-engagement checks, time-resolved assays, and combination-study controls while distinguishing published findings from recommended starting conditions.

• DOTAP for Nucleic Acid Delivery Workflows

  2026-09-24

  Use DOTAP to build and optimize cationic lipid–nucleic acid complexes for transient gene expression, knockdown, and functional genomics. This practical guide pairs a small-scale transfection workflow with troubleshooting advice and explains how immune-metabolism research can inspire testable assay designs—without implying that DOTAP was used in that study.

• Reparixin: CXCR1/2 Inhibition in IL-8 Research

  2026-09-23

  Reparixin is a CXCR1/2 inhibitor for studying chemokine signaling and neutrophil migration. It offers a testable way to examine CXCL8-receptor involvement, but the MRSA extracellular-vesicle study discussed here did not test Reparixin itself.

• Epalrestat Workflow for Aldose Reductase Research

  2026-09-23

  Build reproducible Epalrestat experiments around polyol pathway inhibition, redox measurements, and KEAP1/Nrf2-focused neuroprotection assays. The workflow also shows how to cautiously extend aldose reductase studies into fructose-metabolism and cancer research without overstating translational maturity.

• HotStart qPCR Master Mix for RCC Assay Design

  2026-09-22

  Discover how HotStart qPCR Master Mix supports mechanism-focused gene expression analysis in renal cell carcinoma research. This guide translates albiflorin findings into practical assay decisions involving specificity, inhibition tolerance, ROX normalization, and melt curve interpretation.

• BMP4-GPX4 Protects RGCs in High-IOP Glaucoma

  2026-09-22

  The reference study identifies a BMP4-GPX4 response as a potential link between ferroptosis control and retinal stem cell differentiation in an NMDA-induced mouse glaucoma model. Its findings connect reduced oxidative and iron-related injury with improved retinal ganglion cell protection and a more supportive environment for transplanted retinal stem cells.

• Ribonuclease R: From CircRNA Enrichment to Translation

  2026-09-21

  Circular RNA research is moving from cataloging molecules to explaining how they shape inflammation and DNA repair. This thought-leadership guide connects RNase R-based enrichment with the circ_0042103/TAF15/NER findings in pulpitis and presents a rigorous validation strategy for translational researchers.

• EPZ-6438: Reframing EZH2 Inhibition for Translation

  2026-09-20

  EPZ-6438 offers translational researchers a precise way to interrogate EZH2–PRC2 biology, connect H3K27me3 loss with tumor-suppressor reactivation, and evaluate therapeutic hypotheses across lymphoma, rhabdoid tumor, and HPV-associated cervical cancer models.

• PDGF-BB in Pulmonary Hypertension Assays

  2026-09-19

  A mechanistic framework for using PDGF-BB, murine recombinant protein, to connect controlled smooth muscle cell proliferation assays with emerging metabolic insights in pulmonary hypertension.

• EZH2 Inhibition in HPV-Associated Cervical Cancer

  2026-09-18

  The 2025 reference study evaluates EPZ6438 and ZLD1039 as EZH2 inhibitors in HPV-positive and HPV-negative cervical cancer models, linking EZH2 blockade to apoptosis, G0/G1 arrest, reduced HPV16 E6/E7 expression, and restoration of tumour-suppressive markers. EPZ6438 showed greater activity in HPV-positive cells and preliminary activity in a chorioallantoic membrane model, while the findings also define important limits for interpreting toxicity and clinical translation.

• Olsalazine Sodium: Assay Workflow Guide

  2026-09-18

  A scenario-based guide to using Olsalazine Sodium in cell viability, proliferation, inflammation, and colorectal cancer research. It explains how SKU A8490 addresses solvent compatibility, preparation, interpretation, and vendor-selection challenges using documented physicochemical and biological data.

• Sulfo-NHS-SS-Biotin: A Smarter Surface Assay

  2026-09-17

  Sulfo-NHS-SS-Biotin enables spatially restricted, reversible protein labeling for cell-surface and purification workflows. This guide focuses on assay design, controls, and interpretation rather than simply describing the reagent.

• Recombinant Annexin V for Apoptosis Detection

  2026-09-17

  Brumatti, Sheridan, and Martin developed a practical bacterial expression and purification workflow for soluble polyhistidine-tagged recombinant Annexin V, followed by FITC labeling for flow cytometry and fluorescence microscopy. The study established a reproducible route for detecting phosphatidylserine externalization while clarifying how this apoptosis assay should be interpreted alongside membrane-integrity and morphological measurements.

8447 records 1/564 page Next 12345 下5页 Last page